1997
DOI: 10.1016/s0143-4004(97)80067-7
|View full text |Cite
|
Sign up to set email alerts
|

Hypoxanthine uptake at the fetal side of human placenta proceeds through a nucleobase-preferring carrier and a non-saturable process

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
5
0

Year Published

1999
1999
2005
2005

Publication Types

Select...
4

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 21 publications
0
5
0
Order By: Relevance
“…Preparation viability was assessed by measuring lactic dehydrogenase activity in the perfusate of the isolated perfused cotyledon as described by Penfold et al (1981) and Acevedo et al (1995). In addition, we measured PO 2 in both arterial and venous effluents (Ramirez et al, 1997). The viability of this preparation during the perfusion period was also reflected by the stability of the fetal artery perfusion pressure, fetal perfusate flow rates and volume, which are considered control parameters for defining the viability of the tissue and the quality of the placenta (Hsieh et al, 1992;Malek et al, 1995).…”
Section: Placental Preparationmentioning
confidence: 99%
See 1 more Smart Citation
“…Preparation viability was assessed by measuring lactic dehydrogenase activity in the perfusate of the isolated perfused cotyledon as described by Penfold et al (1981) and Acevedo et al (1995). In addition, we measured PO 2 in both arterial and venous effluents (Ramirez et al, 1997). The viability of this preparation during the perfusion period was also reflected by the stability of the fetal artery perfusion pressure, fetal perfusate flow rates and volume, which are considered control parameters for defining the viability of the tissue and the quality of the placenta (Hsieh et al, 1992;Malek et al, 1995).…”
Section: Placental Preparationmentioning
confidence: 99%
“…After a stabilization period in which the cotyledon was perfused with the Ringer-Krebs solution for at least 40 min, cellular uptake of 2-deoxy-D-[ 3 H]glucose (2-[ 3 H]DG) was measured in relation to an extracellular tracer ([ 14 C]sucrose) using a rapid, single-circulation paired-tracer technique as previously described (Acevedo et al, 1995;Ramirez et al, 1997). A 200 Al bolus containing a mixture of 2-deoxy D-[ 3 H]glucose (4 ACi) and [ 14 C]sucrose (1 ACi) was intra-arterially injected, which was followed by the immediate sequential collection of 8 samples of the venous perfusate at 5 s intervals.…”
Section: D-glucose Uptake In the Placental Cotyledonmentioning
confidence: 99%
“…Preparation viability was assessed by measuring lactic dehydrogenase activity in the perfusate of the isolated perfused cotyledon as described by Penfold et al (1981) and Acevedo et al (1995). In addition, we measured POµ in both arterial and venous effluents (Ram úrez et al 1997). The viability of this preparation during the perfusion period was reflected by the stability of the fetal artery perfusion pressure, fetal perfusate flow rates, and volume, which are considered as control parameters for defining the viability of the tissue and the quality of the placenta (Hsieh et al 1992;Malek et al 1995).…”
mentioning
confidence: 99%
“…After a stabilization period, in which the cotyledon was perfused with the Ringer-Krebs solution for at least 30 min, cellular uptake of ¬_[ÅH]arginine was measured in relation to an extracellular tracer ([ 14 C]sucrose) using a rapid, single-circulation paired-tracer technique, as already described (Acevedo et al 1995;Ram úrez et al 1997). A 200 ìl bolus containing a mixture of ¬_ [ÅH]arginine (4 ìCi; 0·1 ìÒ) and [ 14 C]sucrose (1 ìCi) was intra-arterially injected and was followed by the immediate sequential collection of six samples from the venous perfusate at 1 min intervals.…”
mentioning
confidence: 99%
“…After a stabilization period, in which the cotyledon was perfused with the Ringer-Krebs solution for at least 30 min, cellular uptake of ¬_[ÅH]arginine was measured in relation to an extracellular tracer ([ 14 C]sucrose) using a rapid, single-circulation paired-tracer technique, as already described (Acevedo et al 1995;Ram úrez et al 1997). A 200 ìl bolus containing a mixture of ¬_ [ÅH]arginine (4 ìCi; 0·1 ìÒ) and […”
mentioning
confidence: 99%